參考文獻/References:
[1] 李祥雨,姜勁挺,張倫廣,等.論缺血性股骨頭壞死治療進展[J].遼寧中醫(yī)藥大學學報,2018,20(1):1-3.
[2] 王世鑫,韓杰,王大偉,等.中藥內(nèi)服法治療股骨頭缺血性壞死現(xiàn)狀[J].廣西中醫(yī)藥,2016,39(2):7-9.
[3] 劉維久,艾陽平,李軍.股骨頭壞死MR表現(xiàn)與中醫(yī)證型的相關(guān)研究[J].黑龍江中醫(yī)藥,2015,44(1):38-39.
[4] 魏勇,王鋼.王鋼減毒增效治療非創(chuàng)傷性股骨頭壞死合并類風濕關(guān)節(jié)炎經(jīng)驗介紹[J].新中醫(yī),2017,49(7):157-159.
[5] 陸毅,王浩,安玉芳.名老中醫(yī)滕義和治療股骨頭缺血性壞死的經(jīng)驗[J].黑龍江中醫(yī)藥,2016,(1):46-47.
[6] 丁玲,陳金雄.陳志維辨治股骨頭缺血性壞死經(jīng)驗[J].上海中醫(yī)藥雜志,2016,50(6):20-22.
[7] 袁普衛(wèi),康武林,劉德玉,等.中醫(yī)對股骨頭缺血性壞死病因病機的認識[J].現(xiàn)代中醫(yī)藥,2013,33(6):90-93.
[8] 劉源,郭艷幸,郭珈宜,等.郭艷幸平衡理論論治早期股骨頭壞死[J].世界中西醫(yī)結(jié)合雜志,2016,11(11):1516-1519.
[9] 董國華,邱紅明.邱紅明治療股骨頭壞死經(jīng)驗[J].湖南中醫(yī)雜志,2017,33(3):34-36.
[10] 萬甜,洪昆達,丁懷利.溫針合桃紅四物湯加減治療缺血性股骨頭壞死36例臨床觀察[J].福建中醫(yī)藥大學學報,2014,24(1):49-51.
[11] 賈敏,江蓉星,肖鵬.淺談股骨頭壞死的中醫(yī)病因病機[J].內(nèi)蒙古中醫(yī)藥,2013,32(24):135-136.
[12] MCAVOY S,BAKER KS,MULROONEY D,et al.Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation[J].Biol Blood Marrow Transplant,2010,16(9):1231-1236.
[13] IWAKIRI K,ODA Y,KANESHIRO Y,et al.A less-invasive technique for the prevention of the occurrence of corticosteroid-induced osteonecrosis by a single-point blood sampling after oral administration of midazolam[J].J Bone Joint Surg Br,2012,94(8):30.
[14] 汪亮,劉耀升,劉蜀彬.糖皮質(zhì)激素誘導股骨頭壞死發(fā)病機制的研究進展[J].中華損傷與修復雜志(電子版),2015,10(5):60-66.
[15] 趙敏,夏露,趙學增.糖皮質(zhì)激素所致股骨頭壞死[J].中國醫(yī)院用藥評價與分析,2014,14(4):379-381.
[16] SEN RK,TRIPATHY SK,AGGARWAL S,et al.Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis:a randomized control study[J].J Arthroplasty,2012,27(5):679-686.
[17] 紀志華,賈丙申,于鵬,等.激素性股骨頭壞死中MMP2作用的研究[J].海南醫(yī)學,2017,28(14):2245-2246.
[18] 趙紅星,黃媛霞,徐海斌,等.他汀類藥物治療激素性股骨頭壞死的效果及機制研究[J].西北藥學雜志,2017,32(3):359-363.
[19] ZHANG H,ZHOU F,PAN Z,et al.11β-hydroxysteroid dehydrogenases-2 decreases the apoptosis of MC3T3/MLO-Y4 cells induced by glucocorticoids[J].Biochem Biophys Res Commun,2017,490(4):1399-1406.
[20] YAO W,DAI W,JIANG L,et al.Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength[J].Osteoporos Int,2016,27(1):283-294.
[21] 趙振群,劉萬林,龔瑜林,等.骨髓造血細胞DNA氧化損傷與骨細胞凋亡在早期激素性股骨頭壞死中的表現(xiàn)[J].中國組織工程研究,2015,19(11):1652-1657.
[22] 孟晨陽,劉萬林,白銳,等.激素性股骨頭缺血性壞死發(fā)病機制中的細胞自噬[J].中國組織工程研究,2017,21(8):1280-1287.
[23] 趙振群,張志峰,劉萬林,等.激素性股骨頭壞死過程中低氧誘導因子1α與骨細胞凋亡[J].中國組織工程研究,2015,19(51):8201-8207.
[24] 趙碩,李成.糖皮質(zhì)激素通過線粒體途徑誘導成骨細胞凋亡[J].中國生化藥物雜志,2015,7(7):35-38.
[25] 任力軍.觀察并探討分析住院患者治療股骨頭壞死的相關(guān)因素[J].智慧健康,2017,3(5):199-200.
[26] 謝斌,張小磊,王榮田,等.酒精性股骨頭壞死的發(fā)病特點分析[J].中國醫(yī)刊,2015,50(11):48-50.
[27] 李歡龍,陳昌可,壽碧琪.2011年富陽市成年居民相關(guān)行為生活方式現(xiàn)狀調(diào)查[J].中國農(nóng)村衛(wèi)生事業(yè)管理,2014,34(5):546-548.
[28] YOON BH,KIM TY,SHIN IS,et al.Alcohol intake and the risk of osteonecrosis of the femoral head in Japanese populations:a dose-response meta-analysis of case-control studies[J].Clin Rheumatol,2017,36(11):2517-2524.
[29] 楊云,范海燕,黃健,等.酒精性股骨頭缺血壞死大鼠模型的制備[J].中國組織工程研究,2016,20(27):3977-3983.
[30] 李勁峰.聯(lián)合調(diào)控PPARγ及CGRP基因表達預防酒精性股骨頭壞死的實驗研究[D].鄭州:鄭州大學,2015.
[31] 余華.p53蛋白基因在酒精性股骨頭缺血性壞死患者血液中表達及其致骨細胞凋亡機制研究[J].解剖學研究,2017,39(2):136-139.
[32] 李延紅,龔福太,石耀武,等.原發(fā)性骨質(zhì)疏松癥中西醫(yī)結(jié)合治療現(xiàn)狀及研究進展[J].中國骨質(zhì)疏松雜志,2017,23(5):690-694.
[33] 楊帆,朱振中,李廣翼,等.特發(fā)性和激素性股骨頭壞死塌陷前骨小梁形態(tài)學研究[J].國際骨科學雜志,2015,36(3):198-201.
[34] 徐小文,王亮,馬遠征,等.男性酒精性股骨頭壞死骨密度及血清25羥維生素 D水平研究[J].中國骨質(zhì)疏松雜志,2015,21(5):570-574.
[35] 王琰.鴯鹋股骨頭骨壞死標本微觀結(jié)構(gòu)改變特征及機制研究[D].石河子:石河子大學,2016.
[36] 李志敏,周李學,段璋,等.雙合湯對激素性股骨頭缺血壞死生物力學的影響[J].遼寧中醫(yī)雜志,2017,44(1):163-166.
[37] 曾陽東,何涌,邱維加,等.鐮狀細胞病的骨骼X線表現(xiàn)[J].臨床放射學雜志,2017,36(1):103-106.
[38] DA SILVA JUNIOR GB,DAHER EDE F,DA ROCHA FA.Osteoarticular involvement in sickle cell disease[J].Rev Bras Hematol Hemoter,2012,34(2):156-164.
[39] 洪梅,姜樹華,王海罡.潛水捕撈作業(yè)人員減壓性骨壞死患病情況調(diào)查[J].中國公共衛(wèi)生,2008,24(6):699.
[40] 焦曉敏,匡興亞,王雪梅,等.潛水捕撈業(yè)減壓性骨壞死診斷的分析[J].中國醫(yī)藥指南,2017,15(5):139-140.
[41] LI Y,LIU FX,YUAN C,et al.Association between plasminogen activator inhibitor gene polymorphisms and osteonecrosis of the femoral head susceptibility:A case-control study[J].Medicine(Baltimore),2017,96(42):7047.
[42] HUANG GY,WEI YB,ZHAO GL,et al.Microarray-based screening of differentially expressed genes in glucocorticoid-induced avascular necrosis[J].Mol Med Rep,2017,15(6):3583-3590.
[43] LI JM,LI Y,WANG L.The genetic association between PON1 polymorphisms and osteonecrosis of femoral head:A case-control study[J].Medicine(Baltimore),2017,96(42):8198.
[44] ABDULKAREEM IH.Radiation-induced femoral head necrosis[J].Niger J Clin Pract,2013,16(1):123-126.
[45] 趙忠福,李曉光,劉彩虹,等.齊齊哈爾地區(qū)股骨頭壞死危險因素分析[J].中外醫(yī)療,2016,35(27):20-22.
[46] WU D,SONG D,NI J,et al.Avascular necrosis of the femoral head due to the bilateral injection of heroin into the femoral vein:A case report[J].Exp Ther Med,2013,6(4):1041-1043.
相似文獻/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):21.
[7]李文龍,梅沉成,杜貴強,等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):20.